Cosmopolitan Lifestyle could allay cancer threat

NewsGuard 100/100 Score

If the cancer-inhibiting properties of red wine don't tempt you, why not try a cosmopolitan, the cranberry-based cocktail made famous by the Sex and the City girls.

Scientists have discovered a new compound in cranberries that works in a completely new way to prevent metastasis, the spread of cancer to other parts of the body.

Catherine Neto from the University of Massachusetts-Dartmouth discovered the compound, which prevents cancer cells from breaking away from the primary site and spreading to other parts of the body, a process called metastasis. It inhibits the molecular scissors on the cell surface that snip away at the anchors holding cancer cells in place.

The cranberry compound inhibits the growth of human lung, colon and leukaemia cells in culture, but does not affect healthy cells (Journal of the Science of Food and Agriculture, DOI 10.1002/jsfa.2347).

Navindra Seeram, UCLA Centre for Human Nutrition, says that the effect of this compound is new finding, and that the newly identified compound could form the basis of a new cancer drug. Related compounds in red wine are more active in alcohol, and Seeram thinks the same could be true for this compound.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis